E-drug: HIV drugs: Call for expressions of interest
---------------------------------------------
[E-druggers might be interested to know this process is taking place. BS]
On the web
http://www.unaids.org/publications/documents/care/acc_access/expr_interest.D
EXPRESSION OF INTEREST
In the context of dramatically increasing the affordability of
HIV/AIDS-related care and treatment, the UNAIDS-secretariat, together
with UNICEF, WHO, UNFPA and the World Bank are inviting Expressions
of Interest from:
MANUFACTURERS OF :
� Non-Nucleoside Reverse Transcriptase Inhibitors
� Nucleoside Reverse Transcriptase Inhibitors
� Protease Inhibitors
� Selected anti-infective drugs
� Ganciclovir IV
� Ganciclovir Oral
� Ganciclovir Implant
� Cidofovir IV
� Foscarnet IV
� Azithromycin oral
� Clarithromycin oral
� Rifabutin oral
� Trimethoprim/sulfamethoxazole concentrate for IV administration
� Clindamycin 150 mg oral
� Clindamycin 150mg /amp injectable
� Sulfadiazine 250 mg/amp injectable
� Sulfadiazine 500 mg
� Itraconazole 100 mg oral
� Fluconazole injectable
� Fluconazole 200mg oral
� Amphothericin B 50mg/vial injectable
� Anti-cancer drugs
� Vinblastine 10 mg in vial injectable
� Vincristine sulfate 5 mg in vials
� Drugs for palliative care
� Methadone 5 mg tablet
� Morphine oral solution 10 mg/5 ml (2 suppliers)
� Morphine injectable 10 mg/1 ml ampoule (1 supplier)
� HIV Diagnostic Tests
� HIV Associated laboratory equipment
which are committed to providing the above mentioned products at a
preferential prices to developing countries
The UN programmes and agencies mentioned above are interested in
promoting co-operation with interested parties which:
� Will accelerate sustained access to and use of good quality interventions
for the treatment and care of HIV/AIDS-related illnesses, and the prevention
of mother-to-child transmission of HIV
� Will ensure that care and treatment reach significantly greater numbers
of people in need
� Will be implemented in ways that respond to the specific needs and
requests of individual countries.
Interested Manufacturers should send their application, providing detailed
information about Company Profile, the products offered with indicative
prices, and the availability (registration, license) of those products and
the other pre-qualification criteria set forth below, to:
UNICEF Supply Division
Reference: Accelerated Access to HIV/AIDS care
UNICEF Plads - Freeport
DK-2100, Copenhagen
Denmark
E-mail: supply@unicef.dk
Tel: (45) 35 27 35 27
Fax: (45) 35 26 50 48
Applications must be made by 1 December 2000, 12.00pm (EST) and can be
provided in any of the UN working languages (Arabic, Chinese, English,
French, Russian, Spanish). However, applications that are not made in
English must be accompanied by a certified English translation.
The above-mentioned UN programmes and agencies will make available to
member governments and associated non-governmental agencies (NGOs) a
listing of the manufacturers which the aforesaid programs and
agencies consider to meet the requirements of a pre-qualification
process. Manufacturers included in this listing may be invited to
bid for the supply of products, individually or collectively,
directly by member governments, by the aforesaid UN agencies and/or
by associated NGOs. The following criteria will be taken into account
in the pre-qualification process:
� Product produced under GMP conditions as certified by the national
regulatory authority and/or certified GMP inspectors.
� Obtained national license for production.
� Product registered in accordance with International and other recognized
regional or national Pharmacopoeia.
� Product certificates exist in accordance with the WHO certification
scheme on the quality of pharmaceutical products moving into
international
commerce.
� Manufacturer demonstrates sound financial standing
Only manufacturers THAT CAN SUPPLY APPROPRIATE PRODUCTS OF ASSURED
QUALITY COMPLIANT WITH APPLICABLE REGULATORY AND INTELLECTUAL
PROPERTY LAWS will be considered
The UN agencies reserve the right to determine specific conditions, as for
example the exclusion of companies using child labour, or engaged in the
manufacture of land mines or parts thereof.
[Information provided by "Carinne Bruneton" <remed.75013@wanadoo.fr>]
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.